Furthermore, patients with PsA and psoriasis share some other pathophysiological characteristics (neoangiogenesis, insulin uptake, adipogenesis, lipid metabolism, and immune and epidermal proliferation) [6–8] and genetic aspects, such as peroxisome proliferator activated receptor (PPAR) polymorphism. The gene discussed is PPARA; the disease is psoriasis.